DHR
Danaher Corporation · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 190 | +7 | 438.01M | $83.49B | +10 | −2 |
| Q1 2026 | 185 | -2 | 440.89M | $83.51B | +5 | −8 |
| Q4 2025 | 186 | -1 | 467.58M | $107.03B | +2 | −2 |
| Q3 2025 | 30 | -1 | 269.80M | $53.47B | +1 | −3 |
| Q2 2025 | 29 | +2 | 237.37M | $46.89B | +3 | −1 |
| Q1 2025 | 24 | -1 | 116.89M | $23.96B | +1 | −2 |
| Q4 2024 | 25 | +1 | 111.55M | $25.60B | +1 | — |
| Q3 2024 | 23 | +1 | 81.67M | $22.69B | +2 | −1 |
| Q2 2024 | 22 | — | 81.37M | $20.32B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 24.48M | — | $6.12B | 1.1% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 19.39M | — | $4.84B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 19.39M | — | $4.84B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 13.18M | — | $3.28B | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasivo) | 13.18M | — | $3.28B | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 9.17M | — | $2.29B | 0.3% | n/c | 1 | SEC ↗ |
| 15 | Capital World Investors ✦ | 4.77M | — | $1.19B | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 4.44M | — | $1.11B | 0.5% | n/c | 1 | SEC ↗ |
| 17 | Third Point ✦ | 2.05M | — | $512.19M | 5.9% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 1.91M | — | $476.84M | 0.7% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 777.97K | — | $194.38M | 0.4% | n/c | 1 | SEC ↗ |
| 22 | Gates Foundation Trust ✦ | 373.00K | — | $93.19M | 0.2% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 303.43K | — | $75.81M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Soros Fund Management ✦ | 120.00K | — | $29.98M | 0.9% | n/c | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 114.52K | — | $28.61M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Arrowstreet Capital ✦ | 88.27K | — | $22.05M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Harris Associates (Oakmark) ✦ | 72.21K | — | $18.04M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | PRIMECAP Management ✦ | 66.94K | — | $16.72M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Gotham Asset Management ✦ | 42.65K | — | $10.65M | 0.1% | n/c | 1 | SEC ↗ |
| 32 | Dodge & Cox ✦ | 16.52K | — | $4.13M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 2.70K | — | $674,595 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 2.70K | — | $674,595 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | GAMCO Investors ✦ | 2.24K | — | $558,665 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Bridgewater Associates ✦ | 1.80K | — | $448,731 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 1.23K | — | $306,316 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 2,147 tenedores, 548.39M acciones, $97.77B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 11.31K acc. · $2.46M
Officer, Director · 39.19K acc. · $8.57M
Officer, Director · 7.75K acc. · $1.70M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología